Estadístiques de Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC)
Visites totals
| views | |
|---|---|
| Dual MET and ERBB inhibition overcomes intratumor plasticity in osimertinib-resistant-advanced non-small-cell lung cancer (NSCLC) | 274 |
Visites totals per mes
| views | |
|---|---|
| October 2024 | 0 |
| November 2024 | 0 |
| December 2024 | 1 |
| January 2025 | 0 |
| February 2025 | 2 |
| March 2025 | 0 |
| April 2025 | 0 |
Visites al fitxer
| views | |
|---|---|
| mereu_anno_dual.pdf(legacy) | 239 |
| mereu_anno_dual.pdf | 55 |
Vistes principals per país
| views | |
|---|---|
| United States | 188 |
| Spain | 25 |
| Ireland | 15 |
| Germany | 12 |
| China | 5 |
| Sweden | 5 |
| France | 4 |
| United Kingdom | 4 |
| Japan | 3 |
| Canada | 2 |
| Mexico | 2 |
| Slovenia | 2 |
| Argentina | 1 |
| Australia | 1 |
| Czechia | 1 |
| India | 1 |
| Netherlands | 1 |
| Turkey | 1 |
| Ukraine | 1 |
Visites principals per ciutat
| views | |
|---|---|
| Ashburn | 50 |
| Fairfield | 39 |
| Barcelona | 21 |
| San Ramon | 17 |
| Dublin | 15 |
| Cambridge | 10 |
| Ann Arbor | 9 |
| Boardman | 8 |
| Mountain View | 8 |
| Menlo Park | 7 |
| Seattle | 4 |
| Shenzhen | 4 |
| Jacksonville | 2 |
| Mexico | 2 |
| Redwood City | 2 |
| San Diego | 2 |
| Toronto | 2 |
| Carcastillo | 1 |
| Jerez | 1 |
| Magdeburg | 1 |
| Mumbai | 1 |
| Philadelphia | 1 |
| Rochester | 1 |
| Ríudoms | 1 |
| Shenyang | 1 |
| Suipacha | 1 |
| Telde | 1 |
| Uppsala | 1 |